Rapid onset of action and reduced nasal hyperreactivity: new targets in allergic rhinitis management

被引：39

作者：

Bachert, C. ^{[1
,2
,3
]}

Bousquet, J. ^{[4
,5
,6
]}

Hellings, P. ^{[6
,7
,8
,9
]}

机构：

[1] Ghent Univ Hosp, Ghent, Belgium

[2] Univ Ghent, Upper Airways Res Lab, Ghent, Belgium

[3] Karolinska Inst, Stockholm, Sweden

[4] Fdn FMC VIA LR, Montpellier, France

[5] Univ Versailles St Quentin En Yvelines, UMR S 1168, INSERM,U1168, VIMA Ageing & Chron Dis Epidemiol & Publ Hlth App, Villejuif, Montigny Le Bre, France

[6] European Forum Res & Educ Allergy & Airways Dis E, Brussels, Belgium

[7] Katholieke Univ Leuven, Dept Microbiol & Immunol, Lab Clin Immunol, Herestr 49,Box 1030, B-3000 Louvain, Belgium

[8] Univ Hosp Leuven, Clin Div Otorhinolaryngol Head & Neck Surg, Louvain, Belgium

[9] Acad Med Ctr, Clin Div Otorhinolaryngol Head & Neck Surg, Amsterdam, Netherlands

来源：

CLINICAL AND TRANSLATIONAL ALLERGY | 2018年 / 8卷

关键词：

Allergic rhinitis; MP-AzeFlu; Nasal hyperreactivity; Onset of action; Real life; QUALITY-OF-LIFE; THERAPY MP29-02; MASK-RHINITIS; IMPACT; ASTHMA; ARIA; SYMPTOMS; PATIENT; SPRAY; TECHNOLOGY;

D O I：

10.1186/s13601-018-0210-2

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

Background: This article summarizes a EUFOREA symposium, presented during the European Rhinology Research Forum in Brussels (9-10 November 2017; https://www. rhino logyr esear ch.eu/) which focused on novel pathways and therapeutic approaches in allergic rhinitis (AR). Main body: AR remains under-diagnosed, under-estimated and under-treated. A key component in understanding the AR landscape has been the realization of a significant mismatch between how physicians instruct AR patients to manage their disease and what AR patients actually do in real life. Data from the Allergy Diary (developed by MACVIA ARIA) showed that AR patients take their medication prn, rapidly switch treatments, often experience poor control, use multiple therapies and stop treatment when symptoms are controlled. Better control of AR may be achievable by using an AR treatment which has a rapid onset of action and which effectively targets breakthrough symptoms. Indeed, AR patients report complete symptom relief, lack of breakthrough symptoms, rapid onset of action, safety and use on an ` as needed' basis as key targets for new nasal sprays. MP- AzeFlu comprises intranasal azelastine and fluticasone propionate (FP) in a novel formulation delivered in a single device. It is the first AR treatment to break the 5 min onset of action threshold and provides clinically relevant symptom relief in 15 min, much faster than that noted for FP+ oral loratadine. MP-AzeFlu also significantly reduces nasal hyperresponsiveness (NHR) which may be responsible for the breakthrough symptoms frequently reported by AR patients. Mechanisms underlying MP-AzeFlu's effect include inhibition of mast cell degranulation, stabilization of the mucosal barrier, synergistic inhibition of inflammatory cell recruitment and a unique desensitization of sensory neurons expressing the transient receptor potential A1 and V1 channels. Conclusion: With the most rapid onset of action and onset of clinically-relevant effect of any AR medication currently available, and proven efficacy in the treatment of NHR, MP-AzeFlu is an AR treatment which provides what patients want, and fits how patients manage their AR in real life.

引用

页数：9

共 63 条

[1] Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis [J].

Anolik, Robert .

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2008, 100 (03) :264-271

[2]

[Anonymous], 2017, Med Lett Drugs Ther, V59, pe70

[3] Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA2LEN and AllerGen) [J].

Bousquet, J. ;

Khaltaev, N. ;

Cruz, A. A. ;

Denburg, J. ;

Fokkens, W. J. ;

Togias, A. ;

Zuberbier, T. ;

Baena-Cagnani, C. E. ;

Canonica, G. W. ;

van Weel, C. ;

Agache, I. ;

Ait-Khaled, N. ;

Bachert, C. ;

Blaiss, M. S. ;

Bonini, S. ;

Boulet, L. -P. ;

Bousquet, P. -J. ;

Camargos, P. ;

Carlsen, K. -H. ;

Chen, Y. ;

Custovic, A. ;

Dahl, R. ;

Demoly, P. ;

Douagui, H. ;

Durham, S. R. ;

van Wijk, R. Gerth ;

Kalayci, O. ;

Kaliner, M. A. ;

Kim, Y. -Y. ;

Kowalski, M. L. ;

Kuna, P. ;

Le, L. T. T. ;

Lemiere, C. ;

Li, J. ;

Lockey, R. F. ;

Mavale-Manuel, S. ;

Meltzer, E. O. ;

Mohammad, Y. ;

Mullol, J. ;

Naclerio, R. ;

Hehir, R. E. O. ;

Ohta, K. ;

Ouedraogo, S. ;

Palkonen, S. ;

Papadopoulos, N. ;

Passalacqua, G. ;

Pawankar, R. ;

Popov, T. A. ;

Rabe, K. F. ;

Rosado-Pinto, J. .

ALLERGY, 2008, 63 :8-+

[4] The Allergic Rhinitis and its Impact on Asthma (ARIA) score of allergic rhinitis using mobile technology correlates with quality of life: The MASK study [J].

Bousquet, J. ;

Arnavielhe, S. ;

Bedbrook, A. ;

Fonseca, J. ;

Morais Almeida, M. ;

Todo Bom, A. ;

Annesi-Maesano, I. ;

Caimmi, D. ;

Demoly, P. ;

Devillier, P. ;

Siroux, V. ;

Menditto, E. ;

Passalacqua, G. ;

Stellato, C. ;

Ventura, M. T. ;

Cruz, A. A. ;

Sarquis Serpa, F. ;

da Silva, J. ;

Larenas-Linnemann, D. ;

Rodriguez Gonzalez, M. ;

Burguete Cabanas, M. T. ;

Bergmann, K. C. ;

Keil, T. ;

Klimek, L. ;

Moesges, R. ;

Shamai, S. ;

Zuberbier, T. ;

Bewick, M. ;

Price, D. ;

Ryan, D. ;

Sheikh, A. ;

Anto, J. M. ;

Mullol, J. ;

Valero, A. ;

Haahtela, T. ;

Valovirta, E. ;

Fokkens, W. J. ;

Kuna, P. ;

Samolinski, B. ;

Bindslev-Jensen, C. ;

Eller, E. ;

Bosnic-Anticevich, S. ;

O'Hehir, R. E. ;

Tomazic, P. V. ;

Yorgancioglu, A. ;

Gemicioglu, B. ;

Bachert, C. ;

Hellings, P. W. ;

Kull, I. ;

Melen, E. .

ALLERGY, 2018, 73 (02) :505-510

[5] CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report [J].

Bousquet, J. ;

Onorato, G. L. ;

Bachert, C. ;

Barbolini, M. ;

Bedbrook, A. ;

Bjermer, L. ;

de Sousa, J. Correia ;

Chavannes, N. H. ;

Cruz, A. A. ;

Keenoy, E. De Manuel ;

Devillier, P. ;

Fonseca, J. ;

Hun, S. ;

Kostka, T. ;

Hellings, P. W. ;

Illario, M. ;

Ivancevich, J. C. ;

Larenas-Linnemann, D. ;

Millot-Keurinck, J. ;

Ryan, D. ;

Samolinski, B. ;

Sheikh, A. ;

Yorgancioglu, A. ;

Agache, I. ;

Arnavielhe, S. ;

Bewick, M. ;

Annesi-Maesano, I. ;

Anto, J. M. ;

Bergmann, K. C. ;

Bindslev-Jensen, C. ;

Bosnic-Anticevich, S. ;

Bouchard, J. ;

Caimmi, D. P. ;

Camargos, P. ;

Canonica, G. W. ;

Cardona, V. ;

Carriazo, A. M. ;

Cingi, C. ;

Colgan, E. ;

Custovic, A. ;

Dahl, R. ;

Demoly, P. ;

De Vries, G. ;

Fokkens, W. J. ;

Fontaine, J. F. ;

Gemicioglu, B. ;

Guldemond, N. ;

Gutter, Z. ;

Haahtela, T. ;

Hellqvist-Dahl, B. .

CLINICAL AND TRANSLATIONAL ALLERGY, 2017, 7

[6] Work productivity in rhinitis using cell phones: The MASK pilot study [J].

Bousquet, J. ;

Bewick, M. ;

Arnavielhe, S. ;

Mathieu-Dupas, E. ;

Murray, R. ;

Bedbrook, A. ;

Caimmi, D. P. ;

Vandenplas, O. ;

Hellings, P. W. ;

Bachert, C. ;

Anto, J. M. ;

Bergmann, K. C. ;

Bindslev-Jensen, C. ;

Bosnic-Anticevich, S. ;

Bouchard, J. ;

Canonica, G. W. ;

Chavannes, N. H. ;

Cruz, A. A. ;

Dahl, R. ;

Demoly, P. ;

De Vries, G. ;

Devillier, P. ;

Fink-Wagner, A. ;

Fokkens, W. J. ;

Fonseca, J. ;

Guldemond, N. A. ;

Haahtela, T. ;

Hellqvist-Dahl, B. ;

Just, J. ;

Keil, T. ;

Klimek, L. ;

Kowalski, M. L. ;

Kuna, P. ;

Kvedariene, V. ;

Laune, D. ;

Larenas-Linnemann, D. ;

Mullol, J. ;

Pereira, A. M. ;

Carreiro-Martins, P. ;

En, E. Mel ;

Morais-Almeida, M. ;

Nogueira-Silva, L. ;

O'Hehir, R. E. ;

Papadopoulos, N. G. ;

Passalacqua, G. ;

Portejoie, F. ;

Price, D. ;

Ryan, D. ;

Samolinski, B. ;

Sheikh, A. .

ALLERGY, 2017, 72 (10) :1475-1484

[7] Pilot study of mobile phone technology in allergic rhinitis in European countries: the MASK-rhinitis study [J].

Bousquet, J. ;

Caimmi, D. P. ;

Bedbrook, A. ;

Bewick, M. ;

Hellings, P. W. ;

Devillier, P. ;

Arnavielhe, S. ;

Bachert, C. ;

Bergmann, K. C. ;

Canonica, G. W. ;

Chavannes, N. H. ;

Cruz, A. A. ;

Dahl, R. ;

Demoly, P. ;

De Vries, G. ;

Mathieu-Dupas, E. ;

Finkwagner, A. ;

Fonseca, J. ;

Guldemond, N. ;

Haahtela, T. ;

Hellqvist-Dahl, B. ;

Just, J. ;

Keil, T. ;

Klimek, L. ;

Kowalski, M. L. ;

Kuitunen, M. ;

Kuna, P. ;

Kvedariene, V. ;

Laune, D. ;

Pereira, A. M. ;

Carreiro-Martins, P. ;

Melen, E. ;

Morais-Almeida, M. ;

Mullol, J. ;

Muraro, A. ;

Murray, R. ;

Nogueira-Silva, L. ;

Papadopoulos, N. G. ;

Passalacqua, G. ;

Portejoie, F. ;

Price, D. ;

Ryan, D. ;

Samolinski, B. ;

Sheikh, A. ;

Siroux, V. ;

Spranger, O. ;

Bom, A. Todo ;

Tomazic, P. V. ;

Valero, A. ;

Valovirta, E. .

ALLERGY, 2017, 72 (06) :857-865

[8] MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation [J].

Bousquet, J. ;

Schunemann, H. J. ;

Fonseca, J. ;

Samolinski, B. ;

Bachert, C. ;

Canonica, G. W. ;

Casale, T. ;

Cruz, A. A. ;

Demoly, P. ;

Hellings, P. ;

Valiulis, A. ;

Wickman, M. ;

Zuberbier, T. ;

Bosnic-Anticevitch, S. ;

Bedbrook, A. ;

Bergmann, K. C. ;

Caimmi, D. ;

Dahl, R. ;

Fokkens, W. J. ;

Grisle, I. ;

Lodrup Carlsen, K. ;

Mullol, J. ;

Muraro, A. ;

Palkonen, S. ;

Papadopoulos, N. ;

Passalacqua, G. ;

Ryan, D. ;

Valovirta, E. ;

Yorgancioglu, A. ;

Aberer, W. ;

Agache, I. ;

Adachi, M. ;

Akdis, C. A. ;

Akdis, M. ;

Annesi-Maesano, I. ;

Ansotegui, I. J. ;

Anto, J. M. ;

Arnavielhe, S. ;

Arshad, H. ;

Baiardini, I. ;

Baigenzhin, A. K. ;

Barbara, C. ;

Bateman, E. D. ;

Beghe, B. ;

Bel, E. H. ;

Ben Kheder, A. ;

Bennoor, K. S. ;

Benson, M. ;

Bewick, M. ;

Bieber, T. .

ALLERGY, 2015, 70 (11) :1372-1392

[9] Integrated care pathways for airway diseases (AIRWAYS-ICPs) [J].

Bousquet, J. ;

Addis, A. ;

Adcock, I. ;

Agache, I. ;

Agusti, A. ;

Alonso, A. ;

Annesi-Maesano, I. ;

Anto, J. M. ;

Bachert, C. ;

Baena-Cagnani, C. E. ;

Bai, C. ;

Baigenzhin, A. ;

Barbara, C. ;

Barnes, P. J. ;

Bateman, E. D. ;

Beck, L. ;

Bedbrook, A. ;

Bel, E. H. ;

Benezet, O. ;

Bennoor, K. S. ;

Benson, M. ;

Bernabeu-Wittel, M. ;

Bewick, M. ;

Bindslev-Jensen, C. ;

Blain, H. ;

Blasi, F. ;

Bonini, M. ;

Bonini, S. ;

Boulet, L. P. ;

Bourdin, A. ;

Bourret, R. ;

Bousquet, P. J. ;

Brightling, C. E. ;

Briggs, A. ;

Brozek, J. ;

Buhl, R. ;

Bush, A. ;

Caimmi, D. ;

Calderon, M. ;

Calverley, P. ;

Camargos, P. A. ;

Camuzat, T. ;

Canonica, G. W. ;

Carlsen, K. H. ;

Casale, T. B. ;

Cazzola, M. ;

Sarabia, A. M. Cepeda ;

Cesario, A. ;

Chen, Y. Z. ;

Chkhartishvili, E. .

EUROPEAN RESPIRATORY JOURNAL, 2014, 44 (02) :304-323

[10]

Bousquet J, 2004, ALLERGY, V59, P373

← 1 2 3 4 5 6 7 →